Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications
Conditions
Interventions
None listed
Sponsors
SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: Healthy singleton pregnancy after spontaneous conception or after fertility treatment with Six to fourteen weeks of gestation with signed informed consent.
Exclusion criteria
Exclusion criteria: Previous bariatric surgery; â?¸ Known pre-existing diabetes mellitus or under treatment with metformin; â?¸ Known chronic infection like hepatitis or HIV or chronic kidney, liver or heart disease; â?¸ Known maternal history of hypertensive diseases in a previous pregnancy and now under prophylactic acetylsalicylate treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the potential clinical utility of serum biomarkers glycosylated fibronectin (GyFn) for first-trimester prediction of GDM.Timepoint: first-trimester pregnancy prediction of GDM. | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the association between GlyFn and maternal body mass index and other clinical conditions including pregnancy-induced hypertension or pre-eclampsia and fetal conditions such as intrauterine growth restriction.Timepoint: at 24 weeks of pregnancy | — |
Countries
India
Contacts
Public ContactDR INDU LATA
Sanjay Gandhi Postgraduate Institute of Medical sciences
Outcome results
None listed